(LWAY) Lifeway Foods - Ratings and Ratios
Kefir, Cheese, Yogurt, Butter, Sour Cream
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 69.5% |
| Value at Risk 5%th | 81.5% |
| Relative Tail Risk | -28.75% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.14 |
| Alpha | -8.07 |
| CAGR/Max DD | 0.89 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.445 |
| Beta | 0.407 |
| Beta Downside | 0.504 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.45% |
| Mean DD | 16.85% |
| Median DD | 13.81% |
Description: LWAY Lifeway Foods October 26, 2025
Lifeway Foods, Inc. (NASDAQ:LWAY) manufactures and markets probiotic-focused dairy products, most notably drinkable kefir, across the United States and select international markets. Its portfolio also includes European-style soft cheeses, cream-based items, drinkable yogurt, a children-focused kefir line called ProBugs, and traditional butter and sour cream. Brands sold are Lifeway, Fresh Made, GlenOaks Farms, and various private-label contracts, distributed through a mix of direct sales, brokers, and third-party distributors.
Key performance indicators from the most recent fiscal year (2023) show revenue of approximately $475 million, up roughly 12 % year-over-year, with an operating margin near 13 %. The kefir segment alone contributed about 70 % of total sales, reflecting the product’s strong market traction.
Sector-level drivers that underpin Lifeway’s growth include the expanding functional-food category-U.S. kefir sales are projected to compound at ~7 % annually through 2029-as well as rising consumer awareness of gut health and a broader shift toward plant-based and probiotic alternatives. However, input-cost inflation (particularly dairy and packaging) and competitive pressure from both specialty and mainstream dairy players remain material risks.
For a deeper quantitative look at Lifeway’s valuation metrics, you may find the ValueRay platform’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (11.2m TTM) > 0 and > 6% of Revenue (6% = 12.2m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA -17.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 14.89% (prev 15.42%; Δ -0.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 8.10m <= Net Income 11.2m (YES >=105%, WARN >=100%) |
| Net Debt (-22.6m) to EBITDA (20.7m) ratio: -1.10 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.30 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (15.4m) change vs 12m ago 1.03% (target <= -2.0% for YES) |
| Gross Margin 27.27% (prev 26.41%; Δ 0.86pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 203.2% (prev 199.3%; Δ 3.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 284.8 (EBITDA TTM 20.7m / Interest Expense TTM 59.0k) >= 6 (WARN >= 3) |
Altman Z'' 9.14
| (A) 0.28 = (Total Current Assets 53.8m - Total Current Liabilities 23.4m) / Total Assets 109.5m |
| (B) 0.79 = Retained Earnings (Balance) 86.1m / Total Assets 109.5m |
| (C) 0.17 = EBIT TTM 16.8m / Avg Total Assets 100.4m |
| (D) 3.46 = Book Value of Equity 92.6m / Total Liabilities 26.8m |
| Total Rating: 9.14 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 75.95
| 1. Piotroski 5.50pt |
| 2. FCF Yield -0.93% |
| 3. FCF Margin -1.38% |
| 4. Debt/Equity 0.00 |
| 5. Debt/Ebitda -1.10 |
| 6. ROIC - WACC (= 7.63)% |
| 7. RoE 14.51% |
| 8. Rev. Trend 96.78% |
| 9. EPS Trend 68.54% |
What is the price of LWAY shares?
Over the past week, the price has changed by +10.14%, over one month by -5.14%, over three months by -21.03% and over the past year by -0.53%.
Is LWAY a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the LWAY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35 | 43.2% |
| Analysts Target Price | 35 | 43.2% |
| ValueRay Target Price | 31.4 | 28.3% |
LWAY Fundamental Data Overview November 22, 2025
P/E Trailing = 29.0405
P/S = 1.6037
P/B = 4.0867
P/EG = 7.54
Beta = 0.02
Revenue TTM = 204.1m USD
EBIT TTM = 16.8m USD
EBITDA TTM = 20.7m USD
Long Term Debt = 358.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 69.0k USD (from shortTermDebt, last quarter)
Debt = 358.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -22.6m USD (from netDebt column, last quarter)
Enterprise Value = 304.6m USD (327.3m + Debt 358.0k - CCE 23.0m)
Interest Coverage Ratio = 284.8 (Ebit TTM 16.8m / Interest Expense TTM 59.0k)
FCF Yield = -0.93% (FCF TTM -2.83m / Enterprise Value 304.6m)
FCF Margin = -1.38% (FCF TTM -2.83m / Revenue TTM 204.1m)
Net Margin = 5.47% (Net Income TTM 11.2m / Revenue TTM 204.1m)
Gross Margin = 27.27% ((Revenue TTM 204.1m - Cost of Revenue TTM 148.4m) / Revenue TTM)
Gross Margin QoQ = 30.31% (prev 28.57%)
Tobins Q-Ratio = 2.78 (Enterprise Value 304.6m / Total Assets 109.5m)
Interest Expense / Debt = 5.87% (Interest Expense 21.0k / Debt 358.0k)
Taxrate = 30.70% (1.56m / 5.09m)
NOPAT = 11.6m (EBIT 16.8m * (1 - 30.70%))
Current Ratio = 2.30 (Total Current Assets 53.8m / Total Current Liabilities 23.4m)
Debt / Equity = 0.00 (Debt 358.0k / totalStockholderEquity, last quarter 82.8m)
Debt / EBITDA = -1.10 (Net Debt -22.6m / EBITDA 20.7m)
Debt / FCF = 8.01 (negative FCF - burning cash) (Net Debt -22.6m / FCF TTM -2.83m)
Total Stockholder Equity = 76.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.19% (Net Income 11.2m / Total Assets 109.5m)
RoE = 14.51% (Net Income TTM 11.2m / Total Stockholder Equity 76.9m)
RoCE = 21.75% (EBIT 16.8m / Capital Employed (Equity 76.9m + L.T.Debt 358.0k))
RoIC = 15.15% (NOPAT 11.6m / Invested Capital 76.9m)
WACC = 7.52% (E(327.3m)/V(327.6m) * Re(7.52%) + D(358.0k)/V(327.6m) * Rd(5.87%) * (1-Tc(0.31)))
Discount Rate = 7.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.81%
Fair Price DCF = unknown (Cash Flow -2.83m)
EPS Correlation: 68.54 | EPS CAGR: 72.15% | SUE: -0.10 | # QB: 0
Revenue Correlation: 96.78 | Revenue CAGR: 17.74% | SUE: 0.84 | # QB: 1
Additional Sources for LWAY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle